Tuesday, February 14, 2012

Big Pharma’s underhand tactics to promote off-label drugs

You are receiving this email because you subscribed to Nutrition & Healing on 2010-06-04 00:00:00

If you have not already done so, please confirm your subscription here.

Click here if you'd like to unsubscribe from Nutrition & Healing.

14 February 2012

UK Edition

Dear Reader,

What's better than making billions off a hit drug?

Finding another application for the drug and doubling up on profits, obviously!

Of course, the American Food and Drug Administration (FDA) doesn't allow Big Pharma to promote off-label use of drugs — the use of a particular drug for something other than its FDA-approved application. But this is not just the case in the US.

In Europe, the European Medicines Agency (EMA) has also confirmed its dissatisfaction with the practice of off-label medicine use, with the Agency's former executive director, Thomas Lonngren, having stated while in office that "for a European Union (EU) member state to encourage the use of a pharmaceutical for an indication for which it is not licensed would be a breach of EU legislation."

But those clever drug companies aren't going to let a little thing like FDA and EMA regulations bring them down! No siree, they're hard at work finding a way to circumvent the restriction.

In the past, drug giants such as Pfizer and Eli Lilly have been forced to defend themselves, sometimes in criminal trials, against charges of off-label promotion.

However, now in the US, they're switching sides of the courtroom as they're challenging the FDA's rules. They want to say whatever they want in their advertising campaigns, and by golly, they'll fight for that right!

Of course, there's a reason drug companies aren't allowed to rattle off any claims they want in their advertising. Put plainly, pharmaceutical companies cannot promote something as safe and effective when that hasn't been proven.

Seems like pretty solid reasoning to me. It makes sense, right? But then again it's all about the money for Big Pharma. While regulators are thinking safety, they're thinking revenue. It costs big money to go through the FDA's drug approval process for a second use for a drug that's already been approved — money they just don't want to spend.

So they're instead investing the money on a longer-term strategy... fighting for their "freedom." That's right — because pharmaceutical corporations are "people," they can apparently do whatever they like with detailed prescription drug records, all in the name of marketing...uh, I mean, free speech.

Continues below...
Lose As Much As 28 lbs (And Drop 3 Dress Sizes)... In As Little As 10 Weeks...

Discover this truly amazing weight-loss breakthrough, documented in gold-standard medical studies by independent researchers...

These clinical trials found that those who participated in the studies...

  • Lost an average of 28.1 pounds of pure fat in as little as 10 weeks...
  • Dropped an average of THREE dress sizes...
  • Sculpted an average of 6.94 inches off their waistlines...

And this is just the beginning!

Click here to learn more:
An end to angina attacks?

Q: Is there a way to stop angina attacks, or at least make them less severe?

Dr Jonathan V. Wright: Angina pain is usually due to ischaemia, which means lack of blood flow. Attacks are brought on when the arteries that serve the heart narrow and go into spasm. Since rapid infusions of magnesium can quickly relax blood-vessel spasms anywhere in the body, it's ideal for this situation.

Over the last 30 years, I've treated dozens of angina patients with rapid intravenous infusions of magnesium (given along with vitamin B6). These infusions always put an end to the angina attack, and with repeated infusions on a regular basis, angina pain almost always fades away permanently.

Obviously, since this treatment involves IV nutrients, it requires the help of a doctor skilled and knowledgeable in natural medicine.
Bear in mind we are not addressing anyone's personal situation and you should rely on this for informational purposes only. Please consult with your own physician before acting on any recommendations contained herein.
Wishing you the best of health,

Andrew Miller
UK Editor
Nutrition and Healing

P.S. In the latest issue of Nutrition & Healing, Dr. Wright will tell you how treating the most overlooked factor in heart health can reduce your risk of heart attack by 88%... You'll also learn about the human genetic defect that makes supplementing with vitamin C vitally important...PLUS, if you're suffering from diabetes and high cholesterol, we'll tell you all about Nature's cheaper, more effective alternative to the mainstream's latest, side-effect ridden 'blockbuster' drug.

All new members who sign up will receive important updates like these in addition to receiving Dr. Wright's 7 Volume Library of Natural Healing.

Read here for full details.


"Pharma Claims Free Speech to Push Double-Duty Drugs," ABC News (abcnews.go.com)

Your customer number is: 000052221104

You are receiving this email because you have given us permission to contact you. Agora Health Limited presents information and research which is believed to be reliable, but its accuracy cannot be guaranteed. All material in this email alert is provided for information only and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this email alert; instead readers should consult their family doctor and other qualified health professionals on any matter relating to their health and well-being. The information and opinions provided in this email alert are believed to be accurate and sound, based on the best judgement available to the authors. Readers who fail to consult with appropriate health authorities assume the risk of any injuries. The publisher is not responsible for errors or omissions.

Want more?
Visit The Healthier Life website:

To get the very latest breakthrough treatments that are achieving remarkable success

To share your views with our online community or ask a question in our Health Forum

Please do not reply to this email. Messages to the N&H sending address will not be seen by customer services. All correspondence should be sent to healthtips@agorapub.co.uk

Thank you for all your emails which have been flooding in. Here at Agora Health Limited we aim to answer as many of your queries as possible. However, due to the sheer volume of queries we are now receiving each day we cannot guarantee an individual answer to every query. For this reason we will aim to address your queries and health concerns through the e-alert itself rather than individually.

If clicking a link doesn't work
Copy it, and then paste it into your browser's address bar. Select the entire link (which starts with http: and may include more than one line) and then copy it, usually by clicking the "Edit" menu item and then clicking "Copy". Next, open your browser and click in the box where you usually see the Web page address. Paste the link into this box (usually by clicking "Paste" in the " Edit" menu) and click "Go" or "Enter".

Know someone who'd love to receive the N&H E-Tips themselves?
Simply forward this link to anyone you think could benefit from our daily service:

To unsubscribe from the Nutrition and Healing E-alert please go here

Alternatively you can send an email to healthtips@agorapub.co.uk with the letters NTP in the subject line. You will receive one additional email message confirming your removal. Please allow seven days for this to be actioned.

If you do not wish to click on the unsubscribe link, please call our Customer Services department, and one of our representatives will be happy to unsubscribe you. The number to call is 0207 633 3655 between 9.00am-5.30pm, Monday to Friday, , with the exception of Wednesday afternoons when the Customer Services department is closed from 2pm onwards.

thehealthierlife.co.ukHealth Archives | Health ForumContact UsWhitelisting
Copyright 2012. All Rights Reserved. The content of this site may not be redistributed in any way with out written consent of Agora Inc.

No comments:

Post a Comment


Search This Blog

Blog Archive